Lung Health

Driving Advances in Lung Health Through Early Detection

The chest is one of the most challenging anatomical regions to read due to a multitude of diseases and reading complexity. Earlier detection of these conditions leads to more effective treatments and patient outcomes. Learn more about lung diseases, the impact of early detection, and tools to improve detection accuracy and efficiency.

Lung Cancer and COPD are Leading Global Killers

An estimated 228,000 in the U.S. and 2.48 million globally will be diagnosed with lung cancer this year.
Each year, more people die of lung cancer than of colon, breast, and prostate cancers combined.
Nodule search is burdensome with 95% having no findings or benign findings.
COPD is a massive global health issue, affecting over 400 million and is the fourth leading cause of death worldwide.
Pneumothorax is a life-threatening condition and is commonly associated with underlying lung disease and in trauma.

Why is Early Detection So Important?

Early detection of lung cancer and COPD opens up more treatment options and patient outcomes.
Lung cancer 5-year survival rates improve from 12% when detected in late stages to 67% when detected in early stages.
When missed the first time, lung cancer diagnosis is delayed approximately 250 days.
Enrollment in lung cancer screen programs in the U.S. is less than 20%. Getting screened is the best chance for early detection.
Dramatic change in COPD is predictive of future lung cancer.
30-40% of lung cancer screening participants may have undiagnosed emphysema or COPD.
Delayed detection of pneumothorax can be fatal, especially in patients with COPD and other chronic lung disease.

Improving Detection Accuracy and Efficiency

The American Cancer Society cites that the number of deaths from lung cancer continues to drop, due to fewer people smoking and advances in early detection and treatment. Still, according to the NLST, half of all lung cancers are found on the follow-up scan, not the original scan. This means .that early detection is often the key for future success.

ClearRead (TM) Chest is a comprehensive AI suite for chest CTs and X-rays that provides accurate detection and analysis of pulmonary nodules, coronary artery calcification scoring, quantification of hypodense lung tissue, and detection of pneumothorax when minutes count. ClearRead gives clinicians the tools and information they need to make informed decisions about the most prevalent and dangerous chest conditions. ClearRead covers all the bases for a fully-automatic chest AI solution for incidental detection and in lung cancer screening programs.

Learn More

Learn More

Changing the Landscape in Lung Health

Watch this video to learn how AI is driving meaningful improvements in the detection of lung disease.

Contact us

Thank you for your interest in Riverain Technologies. Whether you'd like to arrange a demo, create a service request, or simply share a question or concern with our team, please contact us. We're ready to help.